Q32 Bio Inc.
QTTB
$1.56
-$0.125-7.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -26.50% | 6.97% | |||
| Gross Profit | 26.50% | -6.97% | |||
| SG&A Expenses | -10.90% | -0.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.79% | 4.99% | |||
| Operating Income | 22.79% | -4.99% | |||
| Income Before Tax | 10.24% | -13.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.36% | -3.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.36% | -3.63% | |||
| EBIT | 22.79% | -4.99% | |||
| EBITDA | 22.93% | -5.02% | |||
| EPS Basic | 20.05% | -2.67% | |||
| Normalized Basic EPS | -86.07% | -7.79% | |||
| EPS Diluted | 20.21% | -2.82% | |||
| Normalized Diluted EPS | -86.07% | -7.79% | |||
| Average Basic Shares Outstanding | 0.86% | 0.94% | |||
| Average Diluted Shares Outstanding | 0.86% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||